Intentional non-radical surgery and survival in advanced ovarian cancer: Results of a pilot study

被引:2
作者
Kehoe, S
Herod, J
vanGeene, P
Shafi, M
Redman, C
Luesley, D
Chan, KK
机构
[1] KEELE UNIV,N STAFFORDSHIRE HOSP,NHS TRUST,DEPT OBSTET & GYNAECOL,STOKE ON TRENT,STAFFS,ENGLAND
[2] WOMENS HOSP TRUST,BIRMINGHAM,W MIDLANDS,ENGLAND
关键词
chemoresponse; ovarian cancer; residual disease;
D O I
10.1046/j.1525-1438.1996.06060448.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between 1991 and 1993, 31 patients with bulky advanced ovarian carcinoma were entered into a structured protocol where attempts at radical surgery were deemed inappropriate should one or more bowel resections and/or splenectomy be required in order to possibly achieve optimum debulking, Only diagnostic and palliative procedures were undertaken and all patients had >2 cm residual disease. Adjuvant chemotherapy was administered to 29 patients (25 platinum based). Follow-up of the study group was for a minimum of 24 months and a maximum of 55 months. The overall median survival was 16 months and, for those exposed to platinum agents, 17 months, Complete response to chemotherapy was achieved in 11 (35%) of patients. Median survival in this group was 29 months. Two patients are still alive, 39 and 55 months after primary surgery, This series indicates that avoiding multiorgan resection does not adversely impact on survival, and concerns in proceeding with a prospective randomized trial of primary debulking surgery is advanced ovarian carcinoma are unfounded.
引用
收藏
页码:448 / 451
页数:4
相关论文
共 16 条
[1]   EN-BLOC RESECTION OF EPITHELIAL OVARIAN-TUMORS WITH CONCOMITANT RECTOSIGMOID COLECTOMY - THE KEMH EXPERIENCE [J].
BRIDGES, JE ;
LEUNG, Y ;
HAMMOND, IG ;
MCCARTNEY, AJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (04) :199-202
[2]   FURTHER EVALUATION OF REPRODUCIBILITY AND PROGNOSTIC VALUE OF HISTOLOGIC TYPING AND GRADING IN FIGO STAGE-I OVARIAN-CANCER PATIENTS WITHOUT SYSTEMIC LOCOREGIONAL ADJUVANT TREATMENT [J].
BRUGGHE, J ;
BAAK, JPA ;
WILTSHAW, E ;
FISHER, C .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (04) :262-268
[3]   THE ROLE OF CYTOREDUCTIVE SURGERY IN THE MANAGEMENT OF STAGE-IV EPITHELIAL OVARIAN-CARCINOMA [J].
GOODMAN, HM ;
HARLOW, BL ;
SHEETS, EE ;
MUTO, MG ;
BROOKS, S ;
STELLER, M ;
KNAPP, RC ;
BERKOWITZ, RS .
GYNECOLOGIC ONCOLOGY, 1992, 46 (03) :367-371
[4]  
GRIFFITHS C, 1975, NATL CANCER I MONOGR, V42, P1010
[5]   INTENSIVE SURGICAL AND CHEMOTHERAPEUTIC MANAGEMENT OF ADVANCED OVARIAN CANCER [J].
GRIFFITHS, CT ;
FULLER, AF .
SURGICAL CLINICS OF NORTH AMERICA, 1978, 58 (01) :131-142
[6]   EXTENSIVE PRIMARY CYTOREDUCTIVE SURGERY FOR ADVANCED EPITHELIAL OVARIAN-CANCER [J].
GUIDOZZI, F ;
BALL, JHS .
GYNECOLOGIC ONCOLOGY, 1994, 53 (03) :326-330
[7]   THE INFLUENCE OF CYTOREDUCTIVE SURGERY ON RECURRENCE-FREE INTERVAL AND SURVIVAL IN SMALL-VOLUME STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
HOSKINS, WJ ;
BUNDY, BN ;
THIGPEN, JT ;
OMURA, GA .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :159-166
[8]  
HOSKINS WJ, 1991, SEMIN ONCOL, V18, P213
[9]  
HUNTER RW, 1992, AM J OBSTET GYNECOL, V166, P504
[10]   SURGERY AND PROGNOSIS IN STAGE-III EPITHELIAL OVARIAN-CANCER [J].
ING, G ;
SEMRAD, N ;
JORDAN, S ;
LATINO, F ;
WATRING, WG .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (06) :416-420